- About
- Programs
- News
- Careers
- Contact
- Home
| Management |
Dr. Joe Lewis M.B.A., is co-founder and CEO of Elara Pharmaceuticals. Concurrently he is Head of the joint DKFZ-EMBL Chemical Biology Core Facility where he leads the early discovery projects of both Institutions mainly in the field of oncology. Prior to this he was employed at Anadys Pharmaceuticals Inc., with responsibility for managing the company's global early HCV research and discovery programs. From 1996 to 2001 Dr. Lewis was a Medical Research Council Senior research fellow and group leader at the Wellcome Trust Centre for Cell Biology in Edinburgh, Scotland with research focus on RNA protein interactions. Dr. Lewis obtained his Ph.D. from the Institute for Molecular Pathology / University of Vienna, Austria where he was first to characterize and clone the protein responsible for the human neurological disorder Rett Syndrome. He successfully completed the ESSEC & Mannheim Executive MBA with distinction in the class of 2008. |
 |